Terns Pharmaceuticals Inc
NASDAQ:TERN
Terns Pharmaceuticals Inc
NASDAQ:TERN
Price:
37.79
USD
Market Cap:
$4B
Relative Value
The Relative Value of one
TERN
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 37.79 USD,
Terns Pharmaceuticals Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
TERN Relative Value
HIDDEN
Multiples Across Competitors
TERN Competitors Multiples
Terns Pharmaceuticals Inc Competitors
Terns Pharmaceuticals Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Terns Pharmaceuticals Inc
NASDAQ:TERN
|
4B USD | 0 | -32.9 | -30.9 | -31 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
983.7B USD | 15.1 | 47.7 | 32.1 | 34.2 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.8B USD | 6.2 | 21.9 | 15.2 | 18.6 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
286.9B CHF | 4.7 | 30.6 | 12.9 | 15 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
233.3B GBP | 5.4 | 31.2 | 17.2 | 24.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
241.3B CHF | 5.5 | 22.2 | 13.7 | 17.6 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
302B USD | 4.6 | 16.5 | 10.3 | 12.1 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.4 | 13.3 | 9.7 | 11.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
156.8B USD | 2.5 | 20.2 | 7.5 | 10 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
123.7B USD | 2.6 | 17.5 | 6.8 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
